Skip to main content

Drug Recalls News

News
06/25/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for Focalin XR (dexmethylphenidate HCl) due to incorrect labeling, affecting 7803 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for Focalin XR (dexmethylphenidate HCl) due to incorrect labeling, affecting 7803 bottles.
The US Food and Drug...
06/25/2026
Pharmacy Learning Network
News
06/25/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for chlorthalidone tablets due to the product’s failure to meet dissolution specifications, affecting 11 460 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for chlorthalidone tablets due to the product’s failure to meet dissolution specifications, affecting 11 460 bottles.
The US Food and Drug...
06/25/2026
Pharmacy Learning Network
News
06/25/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for aripiprazole tablets due to a product mix-up, affecting 6143 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for aripiprazole tablets due to a product mix-up, affecting 6143 bottles.
The US Food and Drug...
06/25/2026
Pharmacy Learning Network
News
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network